Bausch Health Cos Gross Profit 2010-2024 | BHC

Bausch Health Cos gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Bausch Health Cos Annual Gross Profit
(Millions of US $)
2023 $6,198
2022 $5,760
2021 $6,040
2020 $5,778
2019 $6,251
2018 $6,029
2017 $6,176
2016 $7,063
2015 $7,862
2014 $5,970
2013 $3,865
2012 $2,511
2011 $1,731
2010 $775
2009 $602
Bausch Health Cos Quarterly Gross Profit
(Millions of US $)
2024-09-30 $1,814
2024-06-30 $1,684
2024-03-31 $1,513
2023-12-31 $1,703
2023-09-30 $1,615
2023-06-30 $1,518
2023-03-31 $1,362
2022-12-31 $1,541
2022-09-30 $1,462
2022-06-30 $1,390
2022-03-31 $1,367
2021-12-31 $1,570
2021-09-30 $1,529
2021-06-30 $1,488
2021-03-31 $1,453
2020-12-31 $1,568
2020-09-30 $1,548
2020-06-30 $1,169
2020-03-31 $1,493
2019-12-31 $1,589
2019-09-30 $1,625
2019-06-30 $1,558
2019-03-31 $1,479
2018-12-31 $1,519
2018-09-30 $1,554
2018-06-30 $1,534
2018-03-31 $1,422
2017-12-31 $1,516
2017-09-30 $1,560
2017-06-30 $1,587
2017-03-31 $1,513
2016-12-31 $1,738
2016-09-30 $1,821
2016-06-30 $1,762
2016-03-31 $1,742
2015-12-31 $2,028
2015-09-30 $2,139
2015-06-30 $2,047
2015-03-31 $1,648
2014-12-31 $1,651
2014-09-30 $1,495
2014-06-30 $1,456
2014-03-31 $1,368
2013-12-31 $1,332
2013-09-30 $967
2013-06-30 $798
2013-03-31 $768
2012-12-31 $702
2012-09-30 $654
2012-06-30 $610
2012-03-31 $544
2011-12-31 $499
2011-09-30 $435
2011-06-30 $436
2011-03-31 $362
2010-12-31 $301
2010-09-30 $146
2010-06-30 $172
2010-03-31 $157
2009-12-31 $168
2009-09-30 $162
2009-06-30 $143
2009-03-31 $128
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.012B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00